| Molecular Epidemiology and Antifungal Susceptibility of Trichophyton Isolates in Greece: Emergence of Terbinafine-Resistant Trichophyton mentagrophytes Type … M Siopi, I Efstathiou, K Theodoropoulos, S Pournaras, J Meletiadis Journal of Fungi 7 (6), 419, 2021 | 60 | 2021 |
| Epidemiological trends of fungemia in Greece with a focus on candidemia during the recent financial crisis: A 10-year survey in a tertiary care academic hospital and review of … M Siopi, A Tarpatzi, E Kalogeropoulou, S Damianidou, A Vasilakopoulou, ... Antimicrobial agents and chemotherapy 64 (3), 10.1128/aac. 01516-19, 2020 | 43 | 2020 |
| Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic … M Siopi, E Mavridou, JW Mouton, PE Verweij, L Zerva, J Meletiadis Journal of Antimicrobial Chemotherapy 69 (6), 1611-1619, 2014 | 34 | 2014 |
| Optimization of Polyene-Azole Combination Therapy against Aspergillosis Using an In Vitro Pharmacokinetic-Pharmacodynamic Model M Siopi, N Siafakas, S Vourli, L Zerva, J Meletiadis Antimicrobial Agents and Chemotherapy 59 (7), 3973-3983, 2015 | 29 | 2015 |
| Activity of Sulbactam-Durlobactam and Comparators Against a National Collection of Carbapenem-Resistant Acinetobacter baumannii Isolates From Greece D Petropoulou, M Siopi, S Vourli, S Pournaras Frontiers in Cellular and Infection Microbiology 11, 814530, 2022 | 28 | 2022 |
| Comparative evaluation of Sensititre YeastOne and CLSI M38-A2 reference method for antifungal susceptibility testing of Aspergillus spp. against echinocandins M Siopi, S Pournaras, J Meletiadis Journal of Clinical Microbiology 55 (6), 1714-1719, 2017 | 24 | 2017 |
| Increasing incidence and shifting epidemiology of candidemia in Greece: results from the first nationwide 10-year survey V Mamali, M Siopi, S Charpantidis, G Samonis, A Tsakris, G Vrioni, ... Journal of Fungi 8 (2), 116, 2022 | 23 | 2022 |
| Dose optimization of voriconazole/anidulafungin combination against Aspergillus fumigatus using an in vitro pharmacokinetic/pharmacodynamic model and … M Siopi, N Siafakas, S Vourli, JW Mouton, L Zerva, J Meletiadis Journal of Antimicrobial Chemotherapy 71 (11), 3135-3147, 2016 | 21 | 2016 |
| A prospective multicenter cohort surveillance study of invasive aspergillosis in patients with hematologic malignancies in Greece: impact of the revised EORTC/MSGERC 2020 criteria M Siopi, S Karakatsanis, C Roumpakis, K Korantanis, H Sambatakou, ... Journal of Fungi 7 (1), 27, 2021 | 18 | 2021 |
| Genetic diversity and antifungal susceptibility patterns of Aspergillus nidulans complex obtained from clinical and environmental sources M Tavakoli, O Rivero‐Menendez, M Abastabar, MT Hedayati, R Sabino, ... Mycoses 63 (1), 78-88, 2020 | 18 | 2020 |
| Epidemiology and incidence of COVID-19-associated pulmonary aspergillosis (CAPA) in a Greek tertiary care academic reference hospital E Paramythiotou, G Dimopoulos, N Koliakos, M Siopi, S Vourli, ... Infectious Diseases and Therapy 10, 1779-1792, 2021 | 17 | 2021 |
| Bioassay for determining voriconazole serum levels in patients receiving combination therapy with echinocandins M Siopi, E Neroutsos, K Zisaki, M Gamaletsou, M Pirounaki, P Tsirigotis, ... Antimicrobial Agents and Chemotherapy 60 (1), 632-636, 2016 | 16 | 2016 |
| Pan-Echinocandin Resistant C. parapsilosis Harboring an F652S Fks1 Alteration in a Patient with Prolonged Echinocandin Therapy M Siopi, A Papadopoulos, A Spiliopoulou, F Paliogianni, N Abou-Chakra, ... Journal of Fungi 8 (9), 931, 2022 | 15 | 2022 |
| Nationwide surveillance of azole-resistant Aspergillus fumigatus environmental isolates in Greece: detection of pan-azole resistance associated with the TR46/Y121F/T289A … M Siopi, O Rivero-Menendez, G Gkotsis, A Panara, NS Thomaidis, ... Journal of Antimicrobial Chemotherapy 75 (11), 3181-3188, 2020 | 15 | 2020 |
| Single-Dose Pharmacodynamics of Amphotericin B against Aspergillus Species in an In Vitro Pharmacokinetic/Pharmacodynamic Model R Al-Saigh, M Siopi, N Siafakas, A Velegraki, L Zerva, J Meletiadis Antimicrobial agents and chemotherapy 57 (8), 3713-3718, 2013 | 14 | 2013 |
| Comparative pharmacokinetics of the three echinocandins in ICU patients E Mainas, O Apostolopoulou, M Siopi, S Apostolidi, E Neroutsos, ... Journal of Antimicrobial Chemotherapy 75 (10), 2969-2976, 2020 | 10 | 2020 |
| A multicentre study to optimize echinocandin susceptibility testing of Aspergillus species with the EUCAST methodology and a broth microdilution colorimetric method J Meletiadis, M Siopi, L Kanioura, KM Jørgensen, DS Perlin, JW Mouton, ... Journal of Antimicrobial Chemotherapy 75 (7), 1799-1806, 2020 | 10 | 2020 |
| Population pharmacokinetics of anidulafungin in ICU patients assessing inter‐and intrasubject variability I Kapralos, E Mainas, O Apostolopoulou, M Siopi, E Neroutsos, ... British Journal of Clinical Pharmacology 87 (3), 1024-1032, 2021 | 9 | 2021 |
| Successful therapy of Candida pulcherrima fungemia in a premature newborn with liposomal amphotericin B and micafungin A Mpakosi, M Siopi, V Falaina, N Siafakas, E Roilides, M Kimouli, ... Medical mycology case reports 12, 24-27, 2016 | 9 | 2016 |
| Development and multicentre validation of an agar-based screening method for echinocandin susceptibility testing of Aspergillus species J Meletiadis, M Siopi, L Kanioura, KM Jørgensen, DS Perlin, JW Mouton, ... Journal of Antimicrobial Chemotherapy 74 (8), 2247-2254, 2019 | 8 | 2019 |
